NEMUS BIOSCIENCE, INC. October 26, 2016Lock-Up Agreement • October 28th, 2016 • Nemus Bioscience, Inc. • Pharmaceutical preparations • New York
Contract Type FiledOctober 28th, 2016 Company Industry JurisdictionThis Lock-Up Agreement is being delivered to you in connection with the Securities Purchase Agreement (the "Purchase Agreement"), dated as of October 26, 2016 by and among Nemus Bioscience, Inc. (the "Company") and the investors party thereto (the "Buyers"), with respect to the issuance of shares of Series C Convertible Preferred Stock of the Company, par value $0.001 per share. Capitalized terms used herein and not otherwise defined herein shall have the respective meanings set forth in the Purchase Agreement.